PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryFeb 1, 2016	Integra LifeSciences to Host Its Fourth Quarter 2015 Earnings Results Conference Call on February 25, 2016 PLAINSBORO, N.J., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its fourth quarter 2015 financial results on Thursday, February 25, 2016. The company has scheduled a conference call for 4:30 PM ET the same day to discuss the results.	View HTML
Toggle SummaryJan 7, 2016	Integra LifeSciences Receives FDA Approval of Integra® Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU) PLAINSBORO, N.J., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that the United States Food and Drug Administration (FDA) has approved the PMA Supplement for Integra ® Dermal Regeneration Template (IDRT) for the treatment of diabetic	View HTML Integra LifeSciences Receives FDA Approval of Integra® Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU) 16.8 KB
Toggle SummaryJan 4, 2016	Integra LifeSciences to Present at the 34th Annual J.P. Morgan Healthcare Conference In January 2016 PLAINSBORO, N.J., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the 34 th Annual J.P. Morgan Healthcare Conference: At 2:30PM PT on Wednesday, January 13, 2016, Mr. Peter Arduini, President and Chief Executive	View HTML Integra LifeSciences to Present at the 34th Annual J.P. Morgan Healthcare Conference In January 2016 13.6 KB
Toggle SummaryNov 18, 2015	Integra LifeSciences to Present at the 27th Annual Piper Jaffray Healthcare Conference and the Oppenheimer 26th Annual Healthcare Conference in December 2015 PLAINSBORO, N.J., Nov. 18, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in December: At 9:30AM ET on Tuesday, December 1, 2015, Mr. Peter Arduini, President and Chief Executive Officer, will	View HTML Integra LifeSciences to Present at the 27th Annual Piper Jaffray Healthcare Conference and the Oppenheimer 26th Annual Healthcare Conference in December 2015 13.7 KB
Toggle SummaryNov 12, 2015	Integra LifeSciences Hosts Investor Day Today, November 12, 2015 in New York City Increases 2018 Financial Outlook	View HTML Integra LifeSciences Hosts Investor Day Today, November 12, 2015 in New York City 15.9 KB
Toggle SummaryNov 3, 2015	Integra LifeSciences Reports Third Quarter 2015 Financial Results Revenue Increased 14.6% to $226.4 Million with Adjusted EPS of $0.75 Adjusted Net Income Increased 15.1% Raised Low End of Full Year 2015 Revenue and EPS Guidance PLAINSBORO, N.J., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial	View HTML Integra LifeSciences Reports Third Quarter 2015 Financial Results 53.8 KB
Toggle SummaryOct 30, 2015	Integra LifeSciences Receives Expanded Indication for CUSA® Excel+ System for Liver Surgery CUSA® Excel+ System is First and Only Ultrasonic Tissue Ablation System Cleared by FDA for Liver Surgery	View HTML Integra LifeSciences Receives Expanded Indication for CUSA® Excel+ System for Liver Surgery 11.9 KB
Toggle SummaryOct 7, 2015	Integra LifeSciences to Host Its Third Quarter 2015 Earnings Results Conference Call on November 3, 2015 Investor Day to be Held November 12, 2015 in New York City	View HTML Integra LifeSciences to Host Its Third Quarter 2015 Earnings Results Conference Call on November 3, 2015 11.2 KB
Toggle SummaryOct 2, 2015	Integra LifeSciences Completes Acquisition of Salto Talaris(R) Total Ankle Replacement and Futura(TM) Silastic Toe Replacement Product Portfolios from Tornier N.V. PLAINSBORO, N.J., Oct. 2, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it closed the acquisition of the United States rights to Tornier's Salto Talaris® and Salto Talaris® XT ankle replacement products and Tornier's Futura™ silastic toe	View HTML Integra LifeSciences Completes Acquisition of Salto Talaris(R) Total Ankle Replacement and Futura(TM) Silastic Toe Replacement Product Portfolios from Tornier N.V. 12.2 KB
Toggle SummarySep 15, 2015	Integra LifeSciences Files Patent Infringement Lawsuit Against HyperBranch Medical Technology, Inc. PLAINSBORO, N.J., Sept. 15, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra filed a lawsuit in the U.S. District Court for the District of Delaware against HyperBranch Medical Technology, Inc.	View HTML Integra LifeSciences Files Patent Infringement Lawsuit Against HyperBranch Medical Technology, Inc. 9.8 KB
Toggle SummarySep 3, 2015	Integra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris(R)) and Silastic Toe Replacement (Futura(TM)) Product Portfolios From Tornier N.V. PLAINSBORO, N.J. and AMSTERDAM, The Netherlands, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) and Tornier N.V. (NASDAQ:TRNX), today announced a definitive agreement under which Integra will acquire the United States rights to Tornier's Salto Talaris® and	View HTML Integra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris(R)) and Silastic Toe Replacement (Futura(TM)) Product Portfolios From Tornier N.V. 19.9 KB
Toggle SummarySep 1, 2015	Integra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion PLAINSBORO, N.J., Sept. 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. "We are pleased to improve our overall capital structure by expanding the size of	View HTML Integra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion 12.1 KB
Toggle SummaryAug 26, 2015	Integra LifeSciences to Present at the Wells Fargo 2015 Healthcare Conference and the 2015 Morgan Stanley Global Healthcare Conference in September PLAINSBORO, N.J., Aug. 26, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conference in September: At 10:20AM ET on Thursday, September 10, 2015, Mr. Glenn Coleman, Chief Financial Officer, will present at the	View HTML Integra LifeSciences to Present at the Wells Fargo 2015 Healthcare Conference and the 2015 Morgan Stanley Global Healthcare Conference in September 10.6 KB
Toggle SummaryAug 25, 2015	Integra LifeSciences Announces FOUNDER Study Results Which Show Increased Rate of Complete Wound Closure and Decreased Time to Complete Wound Closure With Integra(R) Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU) Results Accepted for Publication in Wound Repair and Regeneration	View HTML Integra LifeSciences Announces FOUNDER Study Results Which Show Increased Rate of Complete Wound Closure and Decreased Time to Complete Wound Closure With Integra(R) Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU) 17.4 KB
Toggle SummaryAug 4, 2015	Integra LifeSciences Prices Public Offering of Common Stock PLAINSBORO, N.J., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has priced its previously announced underwritten public offering of 3,300,000 shares of its common stock at $61.00 per share.	View HTML Integra LifeSciences Prices Public Offering of Common Stock 14.1 KB